Genetic Technologies Limited (NASDAQ:GENE) Short Interest Up 8,650.0% in October

Genetic Technologies Limited (NASDAQ:GENE) was the target of a significant increase in short interest in the month of October. As of October 15th, there was short interest totalling 17,500 shares, an increase of 8,650.0% from the September 30th total of 200 shares. Based on an average trading volume of 20,600 shares, the days-to-cover ratio is presently 0.8 days.

Genetic Technologies Price Performance

Shares of GENE stock opened at $0.77 on Friday. Genetic Technologies has a 1 year low of $0.67 and a 1 year high of $3.77. The company has a current ratio of 0.88, a quick ratio of 0.83 and a debt-to-equity ratio of 0.01. The stock has a 50 day simple moving average of $0.81 and a 200 day simple moving average of $1.42.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Genetic Technologies stock. BNP Paribas Financial Markets bought a new stake in Genetic Technologies Limited (NASDAQ:GENE) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 9,100 shares of the biotechnology company’s stock, valued at approximately $26,000. BNP Paribas Financial Markets owned approximately 0.24% of Genetic Technologies at the end of the most recent quarter. 0.63% of the stock is owned by institutional investors.

About Genetic Technologies

Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage people's health in the America, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates through AffinityDNA, EasyDNA, and GeneType/Corporate segments.